Exousia Bio (LMMY) Shares Outstanding (Weighted Average) (2022 - 2025)

Exousia Bio has disclosed Shares Outstanding (Weighted Average) across 4 years of filings, most recently posting $16.8 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $16.8 million, up 115.57% year-over-year; the trailing twelve-month figure through Nov 2025 was $16.8 million (up 115.57% YoY), and the FY2025 annual result was $7.8 million, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) came in at $16.8 million for Q4 2025 at Exousia Bio, up from $7.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $16.8 million in Q4 2025 to a low of $1.6 million in Q2 2022.
• The 4-year median for Shares Outstanding (Weighted Average) is $7.8 million (2023), against an average of $7.2 million.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 248.82% in 2023 and changed 0.0% in 2024, its largest moves.
• Exousia Bio's Shares Outstanding (Weighted Average) stood at $5.0 million in 2022, then surged by 40.0% to $7.0 million in 2023, then climbed by 11.1% to $7.8 million in 2024, then jumped by 115.57% to $16.8 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $16.8 million (Q4 2025), $7.8 million (Q3 2025), and $7.8 million (Q2 2025), per Business Quant data.